Loading...
Loading...
{
"latency": 58,
"ipAddresses": [
"54.208.101.55",
"174.129.30.187"
],
"dns": {
"NS": [
"ns-1399.awsdns-46.org.",
"ns-1654.awsdns-14.co.uk.",
"ns-469.awsdns-58.com.",
"ns-849.awsdns-42.net."
],
"A": [
"54.208.101.55",
"174.129.30.187"
],
"TXT": [
"v=spf1 include:spf.cloudus.oxcs.net -all"
]
}
}
[
{
"url": "https://sigyntherapeutics.com",
"technologies": [
{
"slug": "apache-http-server",
"name": "Apache HTTP Server",
"icon": "Apache.svg",
"cpe": "cpe:2.3:a:apache:http_server:*:*:*:*:*:*:*:*",
"versions": [],
"categories": [
{
"id": 22,
"slug": "web-servers",
"name": "Web servers"
}
],
"confirmedAt": 1724799750
},
{
"slug": "matomo-tag-manager",
"name": "Matomo Tag Manager",
"icon": "Matomo.svg",
"versions": [],
"categories": [
{
"id": 42,
"slug": "tag-managers",
"name": "Tag managers"
}
],
"confirmedAt": 1724799750
},
{
"slug": "matomo-analytics",
"name": "Matomo Analytics",
"icon": "Matomo.svg",
"cpe": "cpe:2.3:a:matomo:matomo:*:*:*:*:*:*:*:*",
"versions": [],
"categories": [
{
"id": 10,
"slug": "analytics",
"name": "Analytics"
}
],
"confirmedAt": 1724799750
},
{
"slug": "jquery",
"name": "jQuery",
"icon": "jQuery.svg",
"cpe": "cpe:2.3:a:jquery:jquery:*:*:*:*:*:*:*:*",
"versions": [
"3.4.1"
],
"categories": [
{
"id": 59,
"slug": "javascript-libraries",
"name": "JavaScript libraries"
}
],
"confirmedAt": 1724799750
},
{
"slug": "google-tag-manager",
"name": "Google Tag Manager",
"icon": "Google Tag Manager.svg",
"versions": [],
"categories": [
{
"id": 42,
"slug": "tag-managers",
"name": "Tag managers"
}
],
"confirmedAt": 1724799750
},
{
"slug": "google-analytics",
"name": "Google Analytics",
"icon": "Google Analytics.svg",
"versions": [
"UA"
],
"categories": [
{
"id": 10,
"slug": "analytics",
"name": "Analytics"
}
],
"confirmedAt": 1724799750
},
{
"slug": "fancybox",
"name": "FancyBox",
"icon": "FancyBox.svg",
"versions": [
"3.5.7"
],
"categories": [
{
"id": 59,
"slug": "javascript-libraries",
"name": "JavaScript libraries"
}
],
"confirmedAt": 1724799750
},
{
"slug": "browser-update-org",
"name": "Browser-Update.org",
"icon": "Browser-Update.org.png",
"versions": [
"3.3.53"
],
"categories": [
{
"id": 5,
"slug": "widgets",
"name": "Widgets"
},
{
"id": 59,
"slug": "javascript-libraries",
"name": "JavaScript libraries"
}
],
"confirmedAt": 1724799750
},
{
"slug": "google-font-api",
"name": "Google Font API",
"icon": "Google Font API.svg",
"versions": [],
"categories": [
{
"id": 17,
"slug": "font-scripts",
"name": "Font scripts"
}
],
"confirmedAt": 1724799750
},
{
"slug": "aos",
"name": "AOS",
"icon": "AOS.svg",
"versions": [],
"categories": [
{
"id": 59,
"slug": "javascript-libraries",
"name": "JavaScript libraries"
}
],
"confirmedAt": 1724799750
},
{
"slug": "rss",
"name": "RSS",
"icon": "RSS.svg",
"versions": [],
"categories": [
{
"id": 19,
"slug": "miscellaneous",
"name": "Miscellaneous"
}
],
"confirmedAt": 1724799750
},
{
"slug": "open-graph",
"name": "Open Graph",
"icon": "Open Graph.svg",
"versions": [],
"categories": [
{
"id": 19,
"slug": "miscellaneous",
"name": "Miscellaneous"
}
],
"confirmedAt": 1724799750
}
]
}
]
{
"error": false,
"result": {
"success": true,
"ogUrl": "https://www.sigyntherapeutics.com",
"ogSiteName": "Sigyn Therapeutics, Inc.",
"ogTitle": "Sigyn Therapeutics, Inc.",
"ogType": "website",
"twitterCard": "summary_large_image",
"ogImage": [
{
"url": "https://d1io3yog0oux5.cloudfront.net/_5ee2b8bd0bc082247cda8303a8f8a531/sigyntherapeutics/db/874/6994/social_image_resized.jpg",
"type": "jpg"
}
],
"ogLocale": "en",
"ogDate": "2024-05-15T12:13:00",
"favicon": "https://d1io3yog0oux5.cloudfront.net/_5ee2b8bd0bc082247cda8303a8f8a531/sigyntherapeutics/files/theme/images/favicons/favicon.ico",
"charset": "utf-8",
"jsonLD": [
{
"@context": "http://schema.org",
"@type": "Corporation",
"name": "Sigyn Therapeutics, Inc.",
"address": {
"@type": "PostalAddress",
"streetAddress": "2468 Historic Decatur Rd. Suite 140",
"addressLocality": "San Diego, CA",
"postalCode": "92106",
"addressCountry": ""
},
"legalName": "Sigyn Therapeutics, Inc.",
"description": "\r\nWe are developing medical devices to treat cancer and infectious disease disorders. Our lineup of therapeutic candidates is among the most expansive in the field of extracorporeal blood purification. To optimize the benefit of drugs to treat cancer, we invented the ImmunePrepTM platform to enhance the performance of immunotherapeutic antibodies; ChemoPrepTM to improve the delivery of chemotherapy; and ChemoPureTM to reduce chemotherapy toxicity. Our lead therapeutic candidate is Sigyn TherapyTM to address infectious disease disorders that are not treatable with drugs. If successfully advanced, our therapies offer to provide strategic value to the pharmaceutical, dialysis, and organ transplant industry.\r\nTo learn more about our endeavors, we encourage you to navigate through our website. Additionally, you can click on the “Investors” button to access our SEC filings and register to receive email news alerts.\r\nOur candidate solutions include: the ImmunePrep™ platform to enhance the activity of antibody-based immunotherapies, ChemoPrep™ to improve the delivery of cancer chemotherapies, ChemoPure™ to reduce the post-treatment toxicity of chemotherapy, and Sigyn Therapy™ to treat pathogen-associated inflammatory disorders that are not addressed with drug therapies. ",
"tickerSymbol": ": SIGY",
"url": "https://www.sigyntherapeutics.com",
"logo": "https://d1io3yog0oux5.cloudfront.net/_5ee2b8bd0bc082247cda8303a8f8a531/sigyntherapeutics/logo.png",
"image": "https://d1io3yog0oux5.cloudfront.net/_5ee2b8bd0bc082247cda8303a8f8a531/sigyntherapeutics/db/874/6994/social_image_resized.jpg",
"sameAs": []
}
],
"requestUrl": "https://sigyntherapeutics.com"
},
"response": {}
}
{
"data": {
"total": 4,
"personal_emails": 4,
"generic_emails": 0,
"department": {
"executive": 3,
"it": 0,
"finance": 0,
"management": 0,
"sales": 0,
"legal": 0,
"support": 0,
"hr": 0,
"marketing": 0,
"communication": 0,
"education": 0,
"design": 0,
"health": 0,
"operations": 0
},
"seniority": {
"junior": 0,
"senior": 0,
"executive": 2
}
},
"meta": {
"params": {
"domain": "sigyntherapeutics.com",
"company": null,
"type": null
}
}
}
{
"status": 200,
"statusText": "",
"headers": {
"cache-control": "no-store, no-cache, must-revalidate, post-check=0, pre-check=0",
"connection": "Keep-Alive",
"content-encoding": "gzip",
"content-length": "6540",
"content-type": "text/html; charset=UTF-8",
"date": "Fri, 07 Feb 2025 23:12:08 GMT",
"expires": "Thu, 19 Nov 1981 08:52:00 GMT",
"keep-alive": "timeout=5, max=100",
"pragma": "no-cache",
"server": "Apache",
"vary": "Accept-Encoding",
"x-frame-options": "SAMEORIGIN",
"set-cookie": "major_announcement=1; path=/; secure"
}
}
{
"Hubspot": "Hubspot provides marketing information and leads via inbounding marketing software.",
"Google Analytics": "Google Analytics offers a host of compelling features and benefits for everyone from senior executives and advertising and marketing professionals to site owners and content developers.",
"Google Universal Analytics": "The analytics.js JavaScript snippet is a new way to measure how users interact with your website. It is similar to the previous Google tracking code, ga.js, but offers more flexibility for developers to customize their implementations.",
"Google Analytics 4": "Google Analytics 4 formerly known as App + Web is a new version of Google Analytics that was released in October 2020.",
"Global Site Tag": "Google's primary tag for Google Measurement/Conversion Tracking, Adwords and DoubleClick.",
"Matomo Tag Manager": "Tag management solution from Matomo.",
"Matomo": "Matomo is an open source web analytics software. It gives interesting reports on your website visitors, your popular pages, the search engines keywords they used, the language they speak and so much more. Previously known as Piwik Web Analytics.",
"QuoteMedia": "Provider of stock market data and research solutions for online brokerages, clearing firms, banks, media portals, public companies, and financial service corporations.",
"Google Font API": "The Google Font API helps you add web fonts to any web page.",
"Google Tag Manager": "Tag management that lets you add and update website tags without changes to underlying website code.",
"Font Awesome": "Iconic font and CSS toolkit.",
"US Privacy User Signal Mechanism": "The US Privacy API (USP API) is a lightweight API used to communicate signals represented in the US Privacy String.",
"Browser-Update": "A service that provides the opportunity to inform your visitors unobtrusively to switch to a newer browser.",
"Corporation Schema": "A company generally with a ticker symbol.",
"PostalAddress Schema": "A mailing address.",
"CloudFront": "Amazon CloudFront is a web service for content delivery. It integrates with other Amazon Web Services to give developers and businesses an easy way to distribute content to end users with low latency, high data transfer speeds, and no commitments.",
"CDN JS": "CloudFlare's CDN with popular javascript frameworks available.",
"Cloudflare JS": "Loads content from Cloudflare CDN.",
"GStatic Google Static Content": "Google has off-loaded static content (Javascript/Images/CSS) to a different domain name in an effort to reduce bandwidth usage and increase network performance for the end user.",
"Apple Mobile Web Clips Icon": "This page contains an icon for iPhone, iPad and iTouch devices.",
"Viewport Meta": "This page uses the viewport meta tag which means the content may be optimized for mobile content.",
"IPhone / Mobile Compatible": "The website contains code that allows the page to support IPhone / Mobile Content.",
"jQuery": "JQuery is a fast, concise, JavaScript Library that simplifies how you traverse HTML documents, handle events, perform animations, and add Ajax interactions to your web pages. jQuery is designed to change the way that you write JavaScript.",
"jQuery 3.4.1": "jQuery version 3.4.1",
"jQuery Validate": "JQuery Form Validation Plugin.",
"Bootstrap.js": "Twitter Bootstrap JS components.",
"Modernizr": "Modernizr allows you to target specific browser functionality in your stylesheet.",
"Events Page": "The website contains a link to an \"Events\" or \"Calendar\" page.",
"DoubleClick.Net": "DoubleClick enables agencies, marketers and publishers to work together successfully and profit from their digital marketing investments. Owned by Google and now referred to as DoubleClick Digital Marketing or Google Enterprise Advertising.",
"SSL by Default": "The website redirects traffic to an HTTPS/SSL version by default.",
"LetsEncrypt": "Let’s Encrypt is a free open Certificate Authority.",
"Amazon": "This site is hosted on Amazon AWS EC2 Infrastructure.",
"Amazon Virginia Region": "Amazon Hosted EC2 Instances in Virginia",
"Amazon Frankfurt Region": "Amazon Hosted EC2 Instances in Frankfurt, Germany.",
"Amazon California Region": "Amazon Hosted EC2 Instances in California",
"Amazon Ireland Region": "Amazon Hosted EC2 Instances in Ireland",
"Amazon Route 53": "Amazon's scalable DNS web service system.",
"SPF": "The Sender Policy Framework is an open standard specifying a technical method to prevent sender address forgery.",
"Apache": "Apache has been the most popular web server on the Internet since April 1996.",
"RSS": "A family of web feed formats used to publish frequently updated content such as blog entries, news headlines or podcasts.",
"Amazon S3 CDN": "Amazon S3 is storage for the Internet. It is designed to make web-scale computing easier for developers."
}
{
"whois.verisign-grs.com": {
"Domain Status": [
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited"
],
"Name Server": [
"NS-1399.AWSDNS-46.ORG",
"NS-1654.AWSDNS-14.CO.UK",
"NS-469.AWSDNS-58.COM",
"NS-849.AWSDNS-42.NET"
],
"Domain Name": "SIGYNTHERAPEUTICS.COM",
"Registry Domain ID": "2430376497_DOMAIN_COM-VRSN",
"Registrar WHOIS Server": "whois.networksolutions.com",
"Registrar URL": "http://networksolutions.com",
"Updated Date": "2024-07-07T06:15:53Z",
"Created Date": "2019-09-05T20:30:37Z",
"Expiry Date": "2025-09-05T20:30:37Z",
"Registrar": "Network Solutions, LLC",
"Registrar IANA ID": "2",
"Registrar Abuse Contact Email": "[email protected]",
"Registrar Abuse Contact Phone": "+1.8777228662",
"DNSSEC": "unsigned",
"URL of the ICANN Whois Inaccuracy Complaint Form": "https://www.icann.org/wicf/",
">>> Last update of whois database": "2025-02-07T23:11:56Z <<<",
"text": [
"For more information on Whois status codes, please visit https://icann.org/epp",
"",
"NOTICE: The expiration date displayed in this record is the date the",
"registrar's sponsorship of the domain name registration in the registry is",
"currently set to expire. This date does not necessarily reflect the expiration",
"date of the domain name registrant's agreement with the sponsoring",
"registrar. Users may consult the sponsoring registrar's Whois database to",
"view the registrar's reported date of expiration for this registration.",
"",
"TERMS OF USE: You are not authorized to access or query our Whois",
"database through the use of electronic processes that are high-volume and",
"automated except as reasonably necessary to register domain names or",
"modify existing registrations; the Data in VeriSign Global Registry",
"Services' (\"VeriSign\") Whois database is provided by VeriSign for",
"information purposes only, and to assist persons in obtaining information",
"about or related to a domain name registration record. VeriSign does not",
"guarantee its accuracy. By submitting a Whois query, you agree to abide",
"by the following terms of use: You agree that you may use this Data only",
"for lawful purposes and that under no circumstances will you use this Data",
"to: (1) allow, enable, or otherwise support the transmission of mass",
"unsolicited, commercial advertising or solicitations via e-mail, telephone,",
"or facsimile; or (2) enable high volume, automated, electronic processes",
"that apply to VeriSign (or its computer systems). The compilation,",
"repackaging, dissemination or other use of this Data is expressly",
"prohibited without the prior written consent of VeriSign. You agree not to",
"use electronic processes that are automated and high-volume to access or",
"query the Whois database except as reasonably necessary to register",
"domain names or modify existing registrations. VeriSign reserves the right",
"to restrict your access to the Whois database in its sole discretion to ensure",
"operational stability. VeriSign may restrict or terminate your access to the",
"Whois database for failure to abide by these terms of use. VeriSign",
"reserves the right to modify these terms at any time.",
"",
"The Registry database contains ONLY .COM, .NET, .EDU domains and",
"Registrars."
]
},
"whois.networksolutions.com": {
"Domain Status": [],
"Name Server": [],
"text": [
"IP Address Has Reached Rate Limit"
]
}
}